The number of lumpectomies was influenced by several factors beyond the initial tumor size, including residual breast disease, residual tumor volume to breast volume ratio, and the presence of BRCA1 and BRCA2 mutational status, consequently leading the surgeon to propose mastectomy despite the technical feasibility of quadrantectomy. This evidence concerns the gene BRCA1 and neoplasm.